Effects of Liver Fibrosis on Islet Function in Patients with Chronic Hepatitis B Complicated with Impaired Fasting Glucose

References

• Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151–166. doi:10.1038/s41575-020-00372-7
   PubMed Web of Science ®Google Scholar
• Lin CY, Adhikary P, Cheng K. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Adv Drug Deliv Rev. 2021;174:127–139. doi:10.1016/j.addr.2021.04.008
   PubMed Web of Science ®Google Scholar
• Garcia-Compean D, Jaquez-Quintana JO, Lavalle-Gonzalez FJ, et al. The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study. Ann Hepatol. 2012;11(2):240–248. doi:10.1016/s1665-2681(19)31030-0
   PubMed Web of Science ®Google Scholar
• Petit JM, Hamza S, Rollot F, et al. Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis. Acta Diabetol. 2014;51(3):455–460. doi:10.1007/s00592-013-0538-y
   PubMed Web of Science ®Google Scholar
• Li YZ, Teng D, Shi XG, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369:11. doi:10.1136/bmj.m997
   Google Scholar
• Iversen J, Vilstrup H, Tygstrup N. Kinetics of glucose metabolism in relation to insulin concentrations in patients with alcoholic cirrhosis and in healthy persons. Gastroenterology. 1984;87(5):1138–1143. doi:10.1016/S0016-5085(84)80075-X
   PubMed Web of Science ®Google Scholar
• Kruszynska YT, Harry DS, Bergman RN, et al. Insulin sensitivity, insulin-secretion and glucose effectiveness in diabetic and nondiabetic cirrhotic-patients. Diabetologia. 1993;36(2):121–128. doi:10.1007/bf00400692
   PubMed Web of Science ®Google Scholar
• Shmueli E, Walker M, Alberti G, et al. Normal splanchnic but impaired peripheral insulin-stimulated glucose uptake in cirrhosis. Hepatology. 1993;18(1):86–95. doi:10.1002/hep.1840180115
   PubMed Web of Science ®Google Scholar
• Petrides AS, Schulzeberge D, Vogt C, et al. Glucose resistance contributes to diabetes-mellitus in cirrhosis. Hepatology. 1993;18(2):284–291. doi:10.1002/hep.1840180210
   PubMed Web of Science ®Google Scholar
• Sakata M, Kawahara A, Kawaguchi T, et al. Decreased expression of insulin and increased expression of pancreatic transcription factor PDX-1 in islets in patients with liver cirrhosis: a comparative investigation using human autopsy specimens. J Gastroenterol. 2013;48(2):277–285. doi:10.1007/s00535-012-0633-9
   PubMed Web of Science ®Google Scholar
• Kuroda T, Hirooka M, Koizumi M, et al. Pancreatic congestion in liver cirrhosis correlates with impaired insulin secretion. Hepatology. 2014;60:390A–391A.
   Web of Science ®Google Scholar
• Orsi E, Grancini V, Menini S, et al. Hepatogenous diabetes: is it time to separate it from type 2 diabetes? Liver Int. 2017;37(7):950–962. doi:10.1111/liv.13337
   PubMed Web of Science ®Google Scholar
• Grancini V, Trombetta M, Lunati ME, et al. Contribution of beta-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: role of severity of liver disease. J Hepatol. 2015;63(6):1484–1490. doi:10.1016/j.jhep.2015.08.011
   PubMed Web of Science ®Google Scholar
• Nishida T, Tsuji S, Tsujii M, et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol. 2006;101(1):70–75. doi:10.1111/j.1572-0241.2005.00307.x
   PubMed Web of Science ®Google Scholar
• Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599. doi:10.1002/hep.29800
   PubMed Web of Science ®Google Scholar
• American Diabetes A. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41:S13–S27. doi:10.2337/dc18-S002
   PubMed Web of Science ®Google Scholar
• Kim BK, Kim DY, Park JY, et al. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int. 2010;30(4):546–553. doi:10.1111/j.1478-3231.2009.02192.x
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva: World Health Organization; 2015.
   Google Scholar
• Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191–2192. doi:10.2337/diacare.21.12.2191
   PubMed Web of Science ®Google Scholar
• Zhang G, Sun X, Wang F, et al. Analysis of epidemiological characteristics of hepatitis B in Chinese population aged 18–59 years and discussion on immunization strategy of hepatitis B vaccine (in Chinese). Chin J Vaccins Immun. 2013;19:266–270. doi:10.19914/j.cjvi.2013.03.018
   Google Scholar
• Li G. Assessment of islet β cell function (in Chinese). Int J Endocrinol Metabol. 2001;2001:225–227.
   Google Scholar
• Najjar SM, Perdomo G. Hepatic insulin clearance: mechanism and physiology. Physiology. 2019;34(3):198–215. doi:10.1152/physiol.00048.2018
   PubMed Web of Science ®Google Scholar
• Gines P, Krag A, Abraldes JG, et al. Liver cirrhosis. Lancet. 2021;398(10308):1359–1376. doi:10.1016/s0140-6736(21)01374-x
   PubMed Web of Science ®Google Scholar
• Merli M, Leonetti F, Riggio O, et al. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology. 1999;30(3):649–654. doi:10.1002/hep.510300306
   PubMed Web of Science ®Google Scholar
• Perseghin G, Mazzaferro V, Sereni LP, et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology. 2000;31(3):694–703. doi:10.1002/hep.510310320
   PubMed Web of Science ®Google Scholar
• Blanco JJ, Herrero JI, Quiroga J, et al. Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl. 2001;7(3):226–233. doi:10.1053/jlts.2001.22183
   PubMed Web of Science ®Google Scholar
• Grancini V, Trombetta M, Lunati ME, et al. Central role of the beta-cell in driving regression of diabetes after liver transplantation in cirrhotic patients. J Hepatol. 2019;70(5):954–962. doi:10.1016/j.jhep.2019.01.015
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Shiratsuki S, Matsuda T, et al. Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension. J Gastroenterol. 2014;49(9):1333–1341. doi:10.1007/s00535-013-0893-z
   PubMed Web of Science ®Google Scholar
• Lomonaco R, Leiva EG, Bril F, et al. Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening. Diabetes Care. 2021;44(2):399–406. doi:10.2337/dc20-1997
   PubMed Web of Science ®Google Scholar
• Ciardullo S, Monti T, Perseghin G. High prevalence of advanced liver fibrosis assessed by transient elastography among US adults with type 2 diabetes. Diabetes Care. 2021;44(2):519–525. doi:10.2337/dc20-1778
   PubMed Web of Science ®Google Scholar